DS Stage III Plasma Cell Myeloma (DBCOND0030430)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT01619761	NK Cells in Cord Blood Transplantation	Cyclophosphamide Fludarabine Lenalidomide Mechlorethamine Mycophenolate mofetil Natural Killer Cell Rituximab Tacrolimus	treatment	1	unknown_status
NCT01605032	Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma	Bortezomib Busulfan Melphalan	treatment	2	completed
NCT01668719	S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma	Bortezomib Bortezomib D-mannitol Dexamethasone Elotuzumab Lenalidomide	treatment	1 / 2	active_not_recruiting
NCT01330173	Vismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma	Vismodegib	treatment	1	completed
NCT01251172	RO4929097 After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma	Mechlorethamine RG-4733	treatment	2	withdrawn
NCT00088855	Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma	Bortezomib Bortezomib D-mannitol Doxorubicin Tetracycline	treatment	2	completed
NCT01936090	Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma	Bortezomib Melphalan	treatment	1	completed
NCT00839956	Bortezomib and Vorinostat in Treating Patients With Multiple Myeloma Who Have Undergone Autologous Stem Cell Transplant	Bortezomib Bortezomib D-mannitol Vorinostat	treatment	2	completed
NCT01028716	Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies	Cyclophosphamide Filgrastim Fludarabine Mycophenolate mofetil Tacrolimus	treatment	2	terminated
NCT01899326	Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant	Desipramine Filgrastim	treatment	Not Available	terminated
NCT00445692	Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma	Clarithromycin Dexamethasone Lenalidomide	treatment	2	completed
NCT01842308	Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma	Carfilzomib Mechlorethamine	treatment	1 / 2	completed
NCT00066638	FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma	Romidepsin	treatment	2	completed